Navigation Links
Hospira to Standardize Intravenous (I.V.) Administration Sets Portfolio to Non-DEHP
Date:5/14/2010

LAKE FOREST, Ill., May 14 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, will expand its commitment to non-DEHP (non-di(2-ethylhexyl) phthalate) products by transitioning customers to its portfolio of non-DEHP intravenous (I.V.) administration sets. This effort reflects the company's focus on patient safety, increased customer efficiency and reduced impact on the environment, and coincides with the CleanMed global conference on environmentally sustainable healthcare, which took place this week in Baltimore.

"By transitioning to non-DEHP sets, Hospira contributes to a cleaner environment, maintains the highest level of patient safety and helps hospitals simplify their inventory management by standardizing Hospira's non-DEHP product line," said Thomas Moore, president, U.S., Hospira. "Our customers have made it clear that they want non-DEHP products, and we're committed to meet this need."

Hospira began introducing non-DEHP sets a number of years ago, and will continue over the next year, with the vast majority of DEHP sets to be discontinued by early 2011.

Hospira's customers appreciate the company's commitment. When'/>"/>

SOURCE Hospira, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim
2. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim and Manufacturing Facility From PLIVA
3. Hospira, Celltrion, Enter Business Cooperation Agreement to Develop and Market Biogeneric Drugs
4. Hospira to Present at Credit Suisse 18th Annual Healthcare Conference Nov. 11
5. Hospira Names Daphne E. Jones Chief Information Officer
6. Hospira Reports Third-Quarter 2009 Results
7. Hospira Supports Disaster Relief Efforts in Haiti With Products and Cash Grants
8. Hospira to Present at J.P. Morgan 28th Annual Healthcare Conference Jan. 13, 2010
9. Hospira to Host Conference Call for Fourth-Quarter 2009 Results and 2010 Projections
10. Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management Offerings
11. Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... N.Y. , Feb. 26, 2015 ... year at the Clearwater Beach Hilton to provide ... technology to plant reliability professionals from around the ... a stellar collection of leaders in the field ... the demand for excellence continues with this year,s ...
(Date:2/26/2015)... 2015 ABIVAX, a clinical stage biotech ... announced that it has dosed in New Zealand ... trial of ABX203 which is taking place in several countries ... is designed to assess whether ABX203 can deliver a significant ... controlling viral load for a much longer period of time ...
(Date:2/26/2015)... , February 26, 2015 Medtronic, Inc. ... (U.S) are the leaders in the Saudi Arabia ... neuromodulation market and is expected to lead the market during ... Inc. is the top player in the market, and owns ... specific applications. Interstim and Entera Neurostimulator are some of the ...
Breaking Medicine Technology:UE Systems Renowned "Ultrasound World" Conference Celebrates its 11th Year 2ABIVAX Recruits First Patient in a Pivotal Phase IIb/III Clinical Trial with ABX203, a Novel Immunotherapy Against Chronic Hepatitis B 2ABIVAX Recruits First Patient in a Pivotal Phase IIb/III Clinical Trial with ABX203, a Novel Immunotherapy Against Chronic Hepatitis B 3ABIVAX Recruits First Patient in a Pivotal Phase IIb/III Clinical Trial with ABX203, a Novel Immunotherapy Against Chronic Hepatitis B 4ABIVAX Recruits First Patient in a Pivotal Phase IIb/III Clinical Trial with ABX203, a Novel Immunotherapy Against Chronic Hepatitis B 5Middle East & Africa Internal Neurostimulation/Neuromodulation Market is Expected to Reach $6.1 Million by 2019, at a CAGR of 17.9% from 2014 to 2019 2Middle East & Africa Internal Neurostimulation/Neuromodulation Market is Expected to Reach $6.1 Million by 2019, at a CAGR of 17.9% from 2014 to 2019 3Middle East & Africa Internal Neurostimulation/Neuromodulation Market is Expected to Reach $6.1 Million by 2019, at a CAGR of 17.9% from 2014 to 2019 4
... CENTER CITY, Minn., Dec. 21 William Fals-Stewart,Ph.D., professor ... Rochester in,Rochester, New York, has earned the 2007 Dan ... of partner involvement in the,treatment of female alcoholics. Sponsored ... honors a single published article by a researcher,who has ...
... Health care license revenue increases more than 100% ... 20 HealthMedia, the global,leader in scalable behavior ... continued to experience rapid growth,throughout the third quarter ... HealthMedia Connect(TM) product and was honored for its,leadership ...
Cached Medicine Technology:Fals-Stewart Earns Hazelden's 2007 Dan Anderson Research Award 2Fals-Stewart Earns Hazelden's 2007 Dan Anderson Research Award 3Fals-Stewart Earns Hazelden's 2007 Dan Anderson Research Award 4HealthMedia's Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships 2HealthMedia's Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships 3
(Date:2/26/2015)... Wound Care Advantage (WCA), an ... executive team by adding three key members possessing many ... time two WCA team members were promoted to key ... founded in 2002 and is one of the few ... team believes that providing outstanding patient care is the ...
(Date:2/26/2015)... February 26, 2015 SpendWell Health, ... its launch to its first customer today, opening ... their covered dependents. , SpendWell delivers the ... services, combining real-time price transparency with e-commerce. SpendWell’s ... of routine health care services and allows shoppers ...
(Date:2/26/2015)... Catalent Pharma Solutions, the ... and development solutions for drugs, biologics and ... expanded capabilities within its European Clinical Supply ... in response to increased customer demand for ... highly-potent or temperature-sensitive investigational medical products continues ...
(Date:2/26/2015)... (PRWEB) February 26, 2015 Participants ... Initiatives: What’s Working? What’s Not? What’s New? ,” ... dual-eligibles programs to achieve strong outcomes for duals-plan ... been happening in the implementation phase of programs ... been made? Which ones need to be implemented ...
(Date:2/26/2015)... February 26, 2015 The Reproductive Science ... their newly renovated office in Lawrenceville, NJ. ... Center of New Jersey’s physicians, and NJ Top Docs, ... care in the areas of infertility and reproductive medicine. ... excellent success rates and providing current, high quality medical ...
Breaking Medicine News(10 mins):Health News:Wound Center Management Leader WCA Expands Its Team to Include Additional Industry Experts 2Health News:Wound Center Management Leader WCA Expands Its Team to Include Additional Industry Experts 3Health News:Wound Center Management Leader WCA Expands Its Team to Include Additional Industry Experts 4Health News:SpendWell Launches New Online Health Care Marketplace to Large Employer Group 2Health News:SpendWell Launches New Online Health Care Marketplace to Large Employer Group 3Health News:Catalent Expands European Clinical Packaging Capabilities, Highlighting Growing Industry Need for Specialty Handling 2Health News:Catalent Expands European Clinical Packaging Capabilities, Highlighting Growing Industry Need for Specialty Handling 3Health News:Upcoming AIS Virtual Conference Will Explain What Is and Is Not Working in Medicare-Medicaid Dual Eligibles Programs 2Health News:RSCNJ Is Celebrating the Reopening of Their Newly Renovated Office 2Health News:RSCNJ Is Celebrating the Reopening of Their Newly Renovated Office 3
... 12 (HealthDay News) -- A toxic component of a plant ... failure and upper urinary tract cancer, researchers warn. Aristolochic ... used for centuries and still are used in many countries. ... cancer in Taiwan concluded that aristolochic acid is a primary ...
... THURSDAY, April 12 (HealthDay News) -- More unmarried women who ... a new government report shows. Twenty-seven percent of births ... threefold increase from 1985, researchers from the U.S. Centers for ... births outside of marriage, one parent isn,t present. But our ...
... of its kind study conducted by researchers at Boston ... one fall requiring first responder emergency medical services response ... Logan International Airport, with 37 percent of those incidents ... done at the request of the Massachusetts Port Authority ...
... a study published in the Journal of ... risk factors for heart disease, type 2 diabetes ... who did not consume nuts. Tree nut (almonds, ... pistachios and walnuts) consumption specifically, was associated with ...
... international study found that bone marrow transplants are not ... lymphoblastic leukemia (ALL) who fail to attain clinical remission ... induction therapy. The largest study ever of such ... who achieved 10-year survival rates of 72 percent after ...
... Reporter , WEDNESDAY, April 11 (HealthDay News) -- Some ... people with Parkinson,s disease without aggravating other disease symptoms ... Nearly 1 million people in the United States are ... by tremor, slowness and/or rigidity. Parkinson,s disease and depression ...
Cached Medicine News:Health News:Herbal Remedy Ingredient Tied to Cancer, Kidney Failure 2Health News:More Unmarried Couples Having Babies: CDC 2Health News:BMC study shows diverting passengers to elevators could help reduce falls at Logan Airport 2Health News:Tree nut consumption associated with lower body weight and lower prevalence of health risks 2Health News:Chemotherapy proves life-saving for some leukemia patients who fail induction therapy 2Health News:Chemotherapy proves life-saving for some leukemia patients who fail induction therapy 3Health News:Newer Antidepressants May Be Safe for Parkinson's Patients 2Health News:Newer Antidepressants May Be Safe for Parkinson's Patients 3
... Merocel Ophthalmic Products ... superior fiber free products ... and safe cleaning of ... exclusive Merocel material is ...
... Ophthalmic Products provide the ... free products for unparalleled ... cleaning of fine microsurgical ... material is highly absorbent, ...
...
... Ophthalmic Products provide the ... free products for unparalleled ... cleaning of fine microsurgical ... material is highly absorbent, ...
Medicine Products: